- Business Wire•6 days ago
Synergy Pharmaceuticals Inc. today announced that Gary G. Gemignani has been appointed as Executive Vice President and Chief Financial Officer, effective April 17, 2017.
- TheStreet.com•10 days ago
Synergy Pharmaceuticals, Biogen and Insys Therapeutics were among the biotech stock movers in premarket trading on Thursday.
- TheStreet.com•11 days ago
The company's shares were up 24% ahead of market's open on an FDA approval.
SGYP : Summary for Synergy Pharmaceuticals, Inc. - Yahoo Finance
Synergy Pharmaceuticals Inc. (SGYP)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||4.01 x 100|
|Ask||4.28 x 200|
|Day's Range||4.09 - 4.20|
|52 Week Range||2.62 - 7.15|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-3.40|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|